Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.09
-0.23 (-3.14%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $67.97 million as of April 29, 2026. Its market cap has decreased by -34.01% in one year.
Market Cap
67.97M
Enterprise Value
105.17M
1-Year Change
-34.01%
Ranking
Category
Stock Price
$7.09
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $67.97M, a decrease of -96.39%. That is a compound annual growth rate of -26.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 68.00M | -49.48% |
| Dec 31, 2025 | 134.60M | -5.14% |
| Dec 31, 2024 | 141.90M | -21.60% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MAIA Biotechnology | 75.23M |
| Immutep | 75.22M |
| Pliant Therapeutics | 74.92M |
| ImmuCell | 74.73M |
| OS Therapies | 74.41M |
| Fortress Biotech | 73.10M |
| Acrivon Therapeutics | 72.84M |
| Estrella Immunopharma | 71.68M |